SUMITOMO CHEMICAL, Last Fiscal Year Net Income Revised Upward by 52%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Wed Apr 30, 2025 1:30 pm JST Revision

4005 SUMITOMO CHEMICAL COMPANY, LIMITED 【IFRS】

Guidance Update Report

SUMITOMO CHEMICAL COMPANY, LIMITED <4005> [TSE Prime] announced a performance revision in the afternoon session on April 30th (13:30). The consolidated net income for the fiscal year ending March 2025 has been revised upward 52.0%, from the previous forecast of 25 billion yen to 38 billion yen (compared to a loss of 311 billion yen in the previous period).

Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated net income is expected to increase 41.2%, from the previous forecast of 31.5 billion yen to 44.5 billion yen (compared to a loss of 235 billion yen in the same period of the previous year).

Kabutan News

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2024 Prev	1,358,605	58,751	ー	31,527	19.3	6	Oct 30, 2024	IFRS
Oct - Mar, 2024 New	1,364,605	71,751	ー	44,527	27.2	6	Apr 30, 2025	IFRS
Revision Rate	+0.4%	+22.1%	－	+41.2%	+41.3%

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	2,600,000	180,000	ー	25,000	15.3	9	Oct 30, 2024	IFRS
Mar, 2025 New	2,606,000	193,000	ー	38,000	23.2	9	Apr 30, 2025	IFRS
Revision Rate	+0.2%	+7.2%	－	+52.0%	+52.1%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	1,260,018	-355,147	-358,996	-235,492	-144.0	3	May 15, 2024	IFRS
Oct - Mar, 2024 Guidance	1,364,605	71,751	ー	44,527	27.2	6	Apr 30, 2025	IFRS
YoY	+8.3%	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	2,895,283	-30,984	231	6,987	4.3	18	May 15, 2023	IFRS
Mar, 2024	2,446,893	-488,826	-462,792	-311,838	-190.7	9	May 15, 2024	IFRS
Mar, 2025 Guidance	2,606,000	193,000	ー	38,000	23.2	9	Apr 30, 2025	IFRS
YoY	+6.5%	－	－	－	－